DRUG Balance Sheet - Assets & Equity

YoY

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Total Assets

84.00M

+1282.92%

52.00M

+736.23%

56.00M

+764.61%

58.00M

+747.95%

6.00M

-11.26%

6.00M

-25.8%

7.00M

-34.6%

7.00M

-40.37%

7.00M

-43.09%

8.00M

-4.07%

10.00M

-15.1%

12.00M

-25.06%

12.00M

-39.69%

9.00M

-60.3%

12.00M

-54.3%

15.00M

+602.51%

20.00M

22.00M

26.00M

2.00M

Total Current Assets

84.00M

+1308.22%

52.00M

+735.79%

56.00M

+766.25%

58.00M

+751.35%

6.00M

-12.12%

6.00M

-25.19%

7.00M

-34.23%

7.00M

-40.16%

7.00M

-42.98%

8.00M

-5.01%

10.00M

-15.96%

11.00M

-25.84%

12.00M

-40.37%

9.00M

-60.3%

12.00M

-54.31%

15.00M

+603.06%

20.00M

22.00M

26.00M

2.00M

Cash & Short Term Investments

83.00M

+1349.43%

51.00M

+730.14%

56.00M

+838.57%

58.00M

+756.25%

6.00M

-15.23%

6.00M

-23.86%

6.00M

-38.66%

7.00M

-39.69%

7.00M

-41.97%

8.00M

-5.9%

10.00M

-15.66%

11.00M

-25.84%

12.00M

-41.15%

9.00M

-60.74%

11.00M

-54.94%

15.00M

+616.87%

20.00M

22.00M

25.00M

2.00M

Loans & Receivables - Net

413.00K

+722.46%

273.00K

+1481.77%

234.00K

-57.78%

67.00K

+48.8%

50.00K

+35.81%

17.00K

-83.38%

553.00K

+1558.27%

45.00K

-24.02%

37.00K

-76.26%

104.00K

+7.51%

33.00K

-83.99%

59.00K

-60.4%

156.00K

+41.43%

96.00K

+23.66%

208.00K

+467.14%

150.00K

+29838%

110.00K

78.00K

37.00K

500.00

Prepaid Expenses

988.00K

+356.04%

708.00K

+1114.74%

401.00K

+2521.23%

258.00K

+704.31%

217.00K

+682.28%

58.00K

-58.86%

15.00K

-91.44%

32.00K

-79.72%

28.00K

-83.16%

142.00K

+76.53%

179.00K

+110.01%

158.00K

+11.26%

164.00K

-2.25%

80.00K

-37.31%

85.00K

-66.32%

142.00K

+138.61%

168.00K

128.00K

253.00K

60.00K

Total Non-Current Assets

112.00K

-4.84%

129.00K

+968.12%

155.00K

+411.84%

177.00K

+266.45%

118.00K

+77.16%

12.00K

-85.71%

30.00K

-70.59%

48.00K

-60%

66.00K

-52.17%

85.00K

+4126.25%

103.00K

+5031.9%

121.00K

+5937.55%

139.00K

+6843.15%

2.00K

Property Plant & Equipment - Net

112.00K

-4.84%

129.00K

+968.12%

155.00K

+411.84%

177.00K

+266.45%

118.00K

+77.16%

12.00K

-85.71%

30.00K

-70.59%

48.00K

-60%

66.00K

-52.17%

85.00K

103.00K

121.00K

139.00K

Intangible Assets - Net

-100%

0.00

-100%

2.00K

Total Liabilities

2.00M

+318.23%

668.00K

+273.87%

727.00K

-14.07%

572.00K

-33.08%

568.00K

+102.33%

179.00K

-75.69%

846.00K

-18.71%

854.00K

+46.6%

281.00K

-81.82%

735.00K

+90.7%

1.00M

+3.69%

583.00K

+19.01%

2.00M

+141.86%

385.00K

+19.35%

1.00M

+145.22%

490.00K

+245.83%

639.00K

323.00K

409.00K

142.00K

Total Current Liabilities

2.00M

+341.73%

605.00K

+238.69%

638.00K

-24.57%

462.00K

-45.97%

529.00K

+88.24%

179.00K

-75.22%

846.00K

-15.91%

854.00K

+61.74%

281.00K

-80.93%

721.00K

+87.06%

1.00M

+0.23%

528.00K

+7.86%

1.00M

+130.59%

385.00K

+19.35%

1.00M

+145.22%

490.00K

+245.83%

639.00K

323.00K

409.00K

142.00K

Accounts Payable & Accruals

2.00M

+400.97%

527.00K

+220.03%

560.00K

-30.93%

389.00K

-51.37%

449.00K

+116.73%

165.00K

-74.42%

811.00K

-13%

800.00K

+74.52%

207.00K

-85.24%

643.00K

+66.98%

932.00K

-7.11%

458.00K

-6.42%

1.00M

+119.95%

385.00K

+19.35%

1.00M

+145.22%

490.00K

+312.48%

639.00K

323.00K

409.00K

119.00K

Short-Term Debt & Current Portion of Long-Term Debt

85.00K

+6.48%

78.00K

+457.85%

78.00K

+123.86%

73.00K

+33.18%

79.00K

+7.93%

14.00K

-81.89%

35.00K

-52.8%

55.00K

-21.96%

74.00K

+8.27%

77.00K

74.00K

70.00K

68.00K

Total Non-Current Liabilities

41.00K

+4.23%

63.00K

89.00K

110.00K

40.00K

-100%

0.00

-100%

0.00

-100%

14.00K

35.00K

55.00K

72.00K

Debt - Long-Term

41.00K

+4.23%

63.00K

89.00K

110.00K

40.00K

-100%

0.00

-100%

0.00

-100%

14.00K

35.00K

55.00K

72.00K

Total Shareholders' Equity

82.00M

+1381.93%

52.00M

+749.77%

56.00M

+880.45%

58.00M

+858.53%

6.00M

-16.09%

6.00M

-21.05%

6.00M

-36.45%

6.00M

-44.99%

7.00M

-37.41%

8.00M

-8.4%

9.00M

-16.85%

11.00M

-26.51%

11.00M

-45.66%

8.00M

-61.47%

11.00M

-57.52%

15.00M

+627.11%

19.00M

22.00M

25.00M

2.00M

Shareholders' Equity

82.00M

+1381.93%

52.00M

+749.77%

56.00M

+880.45%

58.00M

+858.53%

6.00M

-16.09%

6.00M

-21.05%

6.00M

-36.45%

6.00M

-44.99%

7.00M

-37.41%

8.00M

-8.4%

9.00M

-16.85%

11.00M

-26.51%

11.00M

-45.66%

8.00M

-61.47%

11.00M

-57.52%

15.00M

+627.11%

19.00M

22.00M

25.00M

2.00M

Common Equity Attributable to Parent Shareholders

82.00M

+1381.93%

52.00M

+749.77%

56.00M

+880.45%

58.00M

+858.53%

6.00M

-16.09%

6.00M

-21.05%

6.00M

-36.45%

6.00M

-44.99%

7.00M

-37.41%

8.00M

-8.4%

9.00M

-16.85%

11.00M

-26.51%

11.00M

-45.66%

8.00M

-61.47%

11.00M

-57.52%

15.00M

+627.11%

19.00M

22.00M

25.00M

2.00M

Total Liabilities & Equity

84.00M

+1282.92%

52.00M

+736.23%

56.00M

+764.61%

58.00M

+747.95%

6.00M

-11.26%

6.00M

-25.8%

7.00M

-34.6%

7.00M

-40.37%

7.00M

-43.09%

8.00M

-4.07%

10.00M

-15.1%

12.00M

-25.06%

12.00M

-39.69%

9.00M

-60.3%

12.00M

-54.3%

15.00M

+602.51%

20.00M

22.00M

26.00M

2.00M

Net Debt

-83.00M

+1377.97%

-51.00M

+729.74%

-56.00M

+841.27%

-58.00M

+760.49%

-6.00M

-16.08%

-6.00M

-23.17%

-6.00M

-38.33%

-7.00M

-39.51%

-7.00M

-41.9%

-8.00M

-6.96%

-10.00M

-16.6%

-11.00M

-26.67%

-11.00M

-41.86%

-9.00M

-60.74%

-11.00M

-54.94%

-15.00M

+616.87%

-20.00M

-22.00M

-25.00M

-2.00M

Working Capital

82.00M

+1401.84%

52.00M

+750.37%

56.00M

+884.52%

58.00M

+865.15%

5.00M

-16.44%

6.00M

-20.48%

6.00M

-36.3%

6.00M

-45.1%

7.00M

-37.65%

8.00M

-9.21%

9.00M

-17.47%

11.00M

-26.94%

10.00M

-46%

8.00M

-61.48%

11.00M

-57.53%

15.00M

+627.72%

19.00M

22.00M

25.00M

2.00M

DRUG Financials

DRUG Financials

Summary

Key Indicators

Income Statement

Balance Sheet

Cash Flow